Does Dapagliflozin Affect Energy Intake and Appetite? A Randomized, Controlled Exploratory Study in Healthy Subjects

7Citations
Citations of this article
43Readers
Mendeley users who have this article in their library.

Abstract

The primary aims of this study were to assess the effects of dapagliflozin versus placebo on energy intake and appetite ratings in healthy individuals. This was a randomized, single-blind, placebo-controlled, 2-period crossover study. In each period, healthy individuals received either dapagliflozin or placebo for 2 weeks. On assessment days, participants were asked to consume a standard preload breakfast. Appetite ratings were measured with 100-mm visual analog scales immediately before and during the 4.25-hour period after breakfast. Energy intake was measured at an ad libitum lunch. Energy intake and appetite responses were assessed at the end of each 2-week treatment period by mixed-design analysis of variance. Eighteen individuals completed all assessments (44% female; mean age, 22.8 years; 44% Caucasian; mean BMI, 25.2 kg/m 2 ). There was no difference in energy intake on dapagliflozin compared to placebo (mean difference, −19.8 kcal; P =.516). Mean differences in prebreakfast desire for salty foods (11.3 mm, P =.094) and postbreakfast desire for sweet foods (8.1 mm, P =.054) trended higher with dapagliflozin relative to placebo. Our data do not support an effect of dapagliflozin on energy intake or appetite measures in young, healthy subjects. Although not statistically significant, the size of the mean differences in prebreakfast desire for salty foods and postbreakfast desire for sweet foods on dapagliflozin were larger than placebo and reflect the drug's natriuretic and glucuretic effects. These findings should be further evaluated in patients with type 2 diabetes.

References Powered by Scopus

Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin

15961Citations
N/AReaders
Get full text

Eta squared and partial eta squared as measures of effect size in educational research

2264Citations
N/AReaders
Get full text

Reproducibility, power and validity of visual analogue scales in assessment of appetite sensations in single test meal studies

1771Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Effects of Dapagliflozin and Combination Therapy With Exenatide on Food-Cue Induced Brain Activation in Patients With Type 2 Diabetes

15Citations
N/AReaders
Get full text

The effects of empagliflozin, dietary energy restriction, or both on appetite-regulatory gut peptides in individuals with type 2 diabetes and overweight or obesity: The SEESAW randomized, double-blind, placebo-controlled trial

8Citations
N/AReaders
Get full text

Effects of glucagon-like peptide-1 receptor agonists and sodium-glucose co-transporter 2 inhibitors on cardiorenal and metabolic outcomes in people without diabetes

8Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Bertran, E., Berlie, H. D., Nixon, A., & Jaber, L. (2019). Does Dapagliflozin Affect Energy Intake and Appetite? A Randomized, Controlled Exploratory Study in Healthy Subjects. Clinical Pharmacology in Drug Development, 8(1), 119–125. https://doi.org/10.1002/cpdd.461

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 13

65%

Researcher 5

25%

Professor / Associate Prof. 1

5%

Lecturer / Post doc 1

5%

Readers' Discipline

Tooltip

Medicine and Dentistry 11

61%

Nursing and Health Professions 3

17%

Psychology 2

11%

Biochemistry, Genetics and Molecular Bi... 2

11%

Save time finding and organizing research with Mendeley

Sign up for free